Evidence map›Paper›PMID 36497209›Full record

ReviewCancers2022

Bone Metastasis of Breast Cancer: Molecular Mechanisms and Therapeutic Strategies.

Lulian Pang, Chen Gan, Jian Xu, Yingxue Jia, Jiaying Chai, Runze Huang, Anlong Li, Han Ge, Sheng Yu, Huaidong Cheng

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Lulian PangDepartment of Oncology, Anhui Medical University, Hefei 230601, China.
Chen GanDepartment of Oncology, Anhui Medical University, Hefei 230601, China.
Jian XuDepartment of Oncology, Anhui Medical University, Hefei 230601, China.
Yingxue JiaDepartment of Oncology, Anhui Medical University, Hefei 230601, China.
Jiaying ChaiDepartment of Oncology, Anhui Medical University, Hefei 230601, China.
Runze HuangDepartment of Oncology, Anhui Medical University, Hefei 230601, China.
Anlong LiDepartment of Oncology, Anhui Medical University, Hefei 230601, China.
Han GeDepartment of Oncology, Anhui Medical University, Hefei 230601, China.
Sheng YuDepartment of Oncology, Anhui Medical University, Hefei 230601, China.ORCID 0000-0001-9881-8625
Huaidong ChengDepartment of Oncology, Anhui Medical University, Hefei 230601, China.
Anhui Medical University · CN

Funding

National Natural Science Foundation of China 81872504
6 · The paper itself

Abstract

Bone metastasis is a common complication of many types of advanced cancer, including breast cancer. Bone metastasis may cause severe pain, fractures, and hypercalcemia, rendering clinical management challenging and substantially reducing the quality of life and overall survival (OS) time of breast cancer patients. Studies have revealed that bone metastasis is related to interactions between tumor cells and the bone microenvironment, and involves complex molecular biological mechanisms, including colonization, osteolytic destruction, and an immunosuppressive bone microenvironment. Agents inhibiting bone metastasis (such as bisphosphate and denosumab) alleviate bone destruction and improve the quality of life of breast cancer patients with bone metastasis. However, the prognosis of these patients remains poor, and the specific biological mechanism of bone metastasis is incompletely understood. Additional basic and clinical studies are urgently needed, to further explore the mechanism of bone metastasis and develop new therapeutic drugs. This review presents a summary of the molecular mechanisms and therapeutic strategies of bone metastasis of breast cancer, aiming to improve the quality of life and prognosis of breast cancer patients and provide a reference for future research directions.

Indexed as

bone metastasesbreast cancermolecular mechanismstherapeutic strategies

Identifiers

PMID36497209
PMCPMC9738274
OpenAlexW4309691161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.